The funds will be deployed to expand the hospital's services into over 15 tier II and tier III cities, with a strong focus on rural outreach through mobile screening camps and advanced diagnostic technology.
Existing investors including IvyCap Ventures, Rebright Partners, Avaana Capital, Merisis Opportunities Fund, Nabventures, Blue Dot Capital, and Artek Chemicals also participated in the round.